Table 1.
Population summary by country (Italy, Austria, and overall)
| Italy (n = 1130) | Austria (n = 282) | Overall (n = 1412) | |
|---|---|---|---|
| Male sex – n (%) | 563 (50) | 126 (45) | 689 (49) |
| Age – median (Q1, Q3) | 65.0 (56.0, 72.0) | 65.0 (53.0, 71.0) | 65.0 (55.0, 72.0) |
| Solid tumor – n (%) | 914 (81) | 222 (79) | 1136 (80) |
| Breast | 188 (17) | 67 (24) | 255 (18) |
| Lung | 162 (14) | 35 (12) | 197 (14) |
| Prostate | 32 (3) | 4 (1) | 36 (3) |
| Colorectal | 222 (20) | 34 (12) | 256 (18) |
| Other solid tumor | 310 (27) | 82 (29) | 392 (28) |
| Hematological malignancy – n (%) | 216 (19) | 60 (21) | 276 (20) |
| Non-Hodgkin’s lymphoma | 108 (10) | 31 (11) | 139 (10) |
| Other hematological malignancy | 108 (10) | 29 (10) | 137 (10) |
| Number of chemotherapy cycles completed since initiation – n (%) | |||
| In first cycle | 154 (14) | 54 (19) | 208 (15) |
| 1–3 | 475 (42) | 126 (45) | 601 (43) |
| 4–6 | 302 (27) | 71 (25) | 373 (26) |
| >6 | 199 (18) | 31 (11) | 230 (16) |
| Current chemotherapy regimen containsa – n (%) | |||
| Platinum | 386 (34) | 91 (32) | 477 (34) |
| Anthracycline | 176 (16) | 59 (21) | 235 (17) |
| Taxane | 158 (14) | 58 (21) | 216 (15) |
| Missingb | 469 (42) | 100 (35) | 569 (40) |
| Currently undergoing radio-chemotherapy – n (%) | 42 (4) | 15 (5) | 57 (4) |
Notes:
a
Patients may be recorded in multiple chemotherapy type categories;
b
An unexpected number of patients had therapies other than those listed on the case report form and were therefore categorized as ‘missing’.